Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Mautner

Showing results (41-50 of 61) with videos related to

Pageof 7
Sort By:
Neurobiology of Disease|August 31, 2000
Enhanced proliferation and potassium conductance of Schwann cells isolated from NF2 schwannomas can be reduced by quinidineC Rosenbaum, M Kamleiter, P Grafe, et al.
Gene Therapy|August 1, 1997
Polyethylenimine (PEI) is a simple, inexpensive and effective reagent for condensing and linking plasmid DNA to adenovirus for gene deliveryA Baker, M Saltik, H Lehrmann, et al.
Gene Therapy|August 5, 2000
A versatile system for receptor-mediated gene delivery permits increased entry of DNA into target cells, enhanced delivery to the nucleus and elevated rates of transgene expressionK D Fisher, K Ulbrich, V Subr, et al.
Prostate Cancer and Prostatic Diseases|August 30, 2007
Combining gene and immunotherapy for prostate cancerJ G Young, N K Green, V Mautner, et al.
Neurogenetics|November 21, 2000
The parental origin of new mutations in neurofibromatosis 2L Kluwe, V Mautner, D M Parry, et al.
American Journal of Human Genetics|March 28, 2003
Elevated risk for MPNST in NF1 microdeletion patientsT De Raedt, H Brems, P Wolkenstein, et al.
Gene Therapy|November 13, 2001
In vivo gene therapy for colon cancer using adenovirus-mediated, transfer of the fusion gene cytosine deaminase and uracil phosphoribosyltransferaseG A Chung-Faye, M J Chen, N K Green, et al.
Annals of the New York Academy of Sciences|June 20, 1978
A large glycoprotein lost from the surfaces of transformed cellsR O Hynes, I U Ali, A T Destree, et al.
Gene Therapy|May 18, 1999
Virus directed enzyme prodrug therapy for ovarian and pancreatic cancer using retrovirally delivered E. coli nitroreductase and CB1954I A McNeish, N K Green, M G Gilligan, et al.
Gene Therapy|May 28, 2004
Enhanced efficacy of Escherichia coli nitroreductase/CB1954 prodrug activation gene therapy using an E1B-55K-deleted oncolytic adenovirus vectorM-J Chen, N K Green, G M Reynolds, et al.
Pageof 7

Showing results (41-50 of 61) with videos related to

Sort By:
Pageof 7
Neurobiology of Disease|August 31, 2000
Enhanced proliferation and potassium conductance of Schwann cells isolated from NF2 schwannomas can be reduced by quinidineC Rosenbaum, M Kamleiter, P Grafe, et al.
Gene Therapy|August 1, 1997
Polyethylenimine (PEI) is a simple, inexpensive and effective reagent for condensing and linking plasmid DNA to adenovirus for gene deliveryA Baker, M Saltik, H Lehrmann, et al.
Gene Therapy|August 5, 2000
A versatile system for receptor-mediated gene delivery permits increased entry of DNA into target cells, enhanced delivery to the nucleus and elevated rates of transgene expressionK D Fisher, K Ulbrich, V Subr, et al.
Prostate Cancer and Prostatic Diseases|August 30, 2007
Combining gene and immunotherapy for prostate cancerJ G Young, N K Green, V Mautner, et al.
Neurogenetics|November 21, 2000
The parental origin of new mutations in neurofibromatosis 2L Kluwe, V Mautner, D M Parry, et al.
American Journal of Human Genetics|March 28, 2003
Elevated risk for MPNST in NF1 microdeletion patientsT De Raedt, H Brems, P Wolkenstein, et al.
Gene Therapy|November 13, 2001
In vivo gene therapy for colon cancer using adenovirus-mediated, transfer of the fusion gene cytosine deaminase and uracil phosphoribosyltransferaseG A Chung-Faye, M J Chen, N K Green, et al.
Annals of the New York Academy of Sciences|June 20, 1978
A large glycoprotein lost from the surfaces of transformed cellsR O Hynes, I U Ali, A T Destree, et al.
Gene Therapy|May 18, 1999
Virus directed enzyme prodrug therapy for ovarian and pancreatic cancer using retrovirally delivered E. coli nitroreductase and CB1954I A McNeish, N K Green, M G Gilligan, et al.
Gene Therapy|May 28, 2004
Enhanced efficacy of Escherichia coli nitroreductase/CB1954 prodrug activation gene therapy using an E1B-55K-deleted oncolytic adenovirus vectorM-J Chen, N K Green, G M Reynolds, et al.
Pageof 7